Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SOX21 | hg38_v1_chr13_-_94712505_94712553 | -0.41 | 1.9e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 7.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 5.7 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 5.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 3.5 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.0 | 3.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.4 | 3.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.6 | 3.1 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.3 | 2.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.0 | 2.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 2.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 5.7 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
1.1 | 5.3 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 4.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 2.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 2.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.8 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 1.7 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 1.5 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 1.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.1 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 5.7 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 4.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 3.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.6 | 3.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 3.1 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 2.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 2.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.5 | 2.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.4 | 1.9 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 5.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 2.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 2.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 1.1 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.7 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 5.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 3.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 3.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 2.8 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 2.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 1.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |